MOMENTUM

A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma

Near Add Your Location

Simon Cancer Center
Indiana University
Indianapolis, IN
  • Accepting patients
Winship Cancer Institute
Emory University
Atlanta, GA
  • Accepting patients
University of Nebraska Medical Center
Fred & Pamela Buffett Cancer Center
Omaha, NE
  • Accepting patients
Alvin J. Siteman Cancer Center
Washington University Medical Campus
St. Louis, MO
  • Accepting patients
University of Wisconsin - Carbone Cancer Center
University of Wisconsin Health
Madison, WI
  • Accepting patients
The START Center - San Antonio
South Texas Accelerated Research Therapeutics
San Antonio, TX
  • Accepting patients
START Midwest
Midwest
Grand Rapids, MI
  • Accepting patients
James R Berenson, MD, Inc.
West Hollywood, CA
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.